Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TYMS | P04818 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | NOS1 | P29475 | 8/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16058737 | 1.00 | AKR1B1 (0.49) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| Pyrophosphoric Acid SCHEMBL2178852 | 0.93 | POLB (0.46) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL29619286 | 0.85 | TYMS (0.66) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL5665622 | 0.85 | TYMS (0.66) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL16681740 | 0.85 | AKR1B1 (0.51) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL17811602 | 0.82 | AKR1B1 (0.45) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| Folic Acid SCHEMBL8897352 | 0.79 | TYMS (0.80) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL3980437 | 0.78 | AKR1B1 (0.47) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| SCHEMBL7639622 | 0.76 | AKR1B1 (0.46) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 | |
| Pteroic Acid SCHEMBL245981 | 0.75 | KDM4E (0.69) | AKR1B1HSD17B10KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025124444-A1 | USE OF HYDROXYPROLINE AND DERIVATIVE THEREOF, BIOLOGICAL HERBICIDE, BROAD-SPECTRUM HERBICIDE, AND WEED CONTROL METHOD | 三亚市国家耐盐碱水稻技术创新中心 | 2025-06-19 | — | — | WO | claimed |
| CN-120130489-A | Application of hydroxyproline and derivatives thereof, biological herbicide, broad-spectrum herbicide and weed control method | 三亚市国家耐盐碱水稻技术创新中心 | 2025-06-13 | — | — | CN | claimed |
| CN-120051271-A | Methods for treating infectious diseases | 欣扬生医股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| US-20240130368-A1 | HERBICIDAL COMPOSITION | NIPPON SODA CO., LTD. (JP) | 2024-04-25 | — | — | US | claimed |
| CN-117546851-A | Herbicidal compositions containing uracil compounds of carboxylate fragments and uses thereof | 江苏中旗科技股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| EP-4316244-A1 | HERBICIDAL COMPOSITION | Nippon Soda Co., Ltd. (JP) | 2024-02-07 | — | — | EP | claimed |
| CN-116429952-B | Depression marker, application thereof in depression diagnosis and evaluation device | 深圳市第二人民医院(深圳市转化医学研究院) | 2024-02-02 | — | — | CN | claimed |
| CN-117500903-A | Yucca schidigera extract for foliar use | 金伯利-克拉克环球有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-11812738-B2 | Polynucleotide molecules for gene regulation in plants | MONSANTO TECHNOLOGY LLC (US) | 2023-11-14 | — | — | US | claimed |
| CN-116867373-A | Herbicidal composition | 日本曹达株式会社 | 2023-10-10 | — | — | CN | claimed |
| WO-2011034263-A1 | METHOD FOR PREDICTING A DRUG TARGET IN PATHOGENIC MICROORGANISMS USING AN ESSENTIAL METABOLITE | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| US-20030023386-A1 | Metabolome profiling methods using chromatographic and spectroscopic data in pattern recognition analysis | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-30 | — | — | US | claimed |
| CN-1376198-A | Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata | ZENECA LTD (GB) | 2002-10-23 | — | — | CN | claimed |
| WO-2002057989-A2 | METHOD FOR METABOLIC PROFILING | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-25 | — | — | WO | claimed |
| CN-1240484-A | Method for conferring insect resistance to monocot plants using peroxidase coding sequences | NOVARTIS AG (CH) | 2000-01-05 | — | — | CN | claimed |
| US-5633444-A | A GENETICALLY ENGINEERED PLANT CELL | RHONE-POULENC AGROCHIMIE LIMITED (FR) | 1997-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240130368-A1 | HERBICIDAL COMPOSITION | CHRM2, DDT, CHRM1 | AKR1B1 3928/4885HSD17B10 3180/4885KDM4E 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.